Mangiferin exhibits anti-cancer properties by inducing G2/M phase cell cycle arrest through the cyclin-dependent kinase 1-cyclin B1 signaling pathway downregulation and apoptotic cell death by inhibiting the PKC-NF-κB pathway [23]. Here, NFKB1 is linked to cancer.